Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:EU EMA/INS/GCP/126568/2023 - Annual Report of the Good Clinical Practice (GCP) Inspectors' Working Group (IWG) 2022 2023 3.1.2 - Organisation

From GxPlex

Revision as of 13:49, 16 July 2026 by Gxplex admin (talk | contribs) (1 revision imported)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search



Document information
Reference EU EMA/INS/GCP/126568/2023

- Annual Report of the Good Clinical Practice (GCP) Inspectors' Working Group (IWG) 2022 2023

Validity area EU
Scope(s) G
Document name EMA/INS/GCP/126568/2023

- Annual Report of the Good Clinical Practice (GCP) Inspectors' Working Group (IWG) 2022

Version / Revision 2023
Status Current
Document type Official guideline
Language(s) EN
Description EMA/INS/GCP/164938/2024

Inspections Office Quality and Safety of Medicines Department

Annual Report of the Good Clinical Practice (GCP) Inspectors' Working Group (IWG) 2023 Adopted by the GCP IWG on 26 November 2024

Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 2 — Unit 2.3.2
Scope G
Document part 3.1.2 - Organisation
Language EN
Original entry by Florian Adragna
Contributors
Tags Critical finding, Major finding, Examples, Delegation, Monitoring

Content

Examples of critical and major findings in the sub-categories of the three main categories "General", "Trial Management", and "Investigational Site" are listed below. [...] Organisation and Personnel: • Delegation of trial specific tasks had not been done and/or documented properly. • Insufficient resources available to perform the trial duties, including timely entry of source data in the eCRF and performance of assessments in real time. • The trial supervision was insufficient to ensure the timely resolution of several significant observations identified during the trial monitoring. [...]